149 related articles for article (PubMed ID: 29474554)
1. Rim domain loops of staphylococcal β-pore forming bi-component toxin S-components recognize target human erythrocytes in a coordinated manner.
Peng Z; Takeshita M; Shibata N; Tada H; Tanaka Y; Kaneko J
J Biochem; 2018 Aug; 164(2):93-102. PubMed ID: 29474554
[TBL] [Abstract][Full Text] [Related]
2. Bacterial two-component and hetero-heptameric pore-forming cytolytic toxins: structures, pore-forming mechanism, and organization of the genes.
Kaneko J; Kamio Y
Biosci Biotechnol Biochem; 2004 May; 68(5):981-1003. PubMed ID: 15170101
[TBL] [Abstract][Full Text] [Related]
3. Tyrosine72 residue at the bottom of rim domain in LukF crucial for the sequential binding of the staphylococcal gamma-hemolysin to human erythrocytes.
Yokota K; Kamio Y
Biosci Biotechnol Biochem; 2000 Dec; 64(12):2744-7. PubMed ID: 11210152
[TBL] [Abstract][Full Text] [Related]
4. The N-terminal amino-latch region of Hlg2 component of staphylococcal bi-component γ-haemolysin is dispensable for prestem release to form β-barrel pores.
Takeda K; Tanaka Y; Kaneko J
J Biochem; 2020 Oct; 168(4):349-354. PubMed ID: 32330256
[TBL] [Abstract][Full Text] [Related]
5. Identification of a domain critical for
Vasquez MT; Lubkin A; Reyes-Robles T; Day CJ; Lacey KA; Jennings MP; Torres VJ
J Biol Chem; 2020 Dec; 295(50):17241-17250. PubMed ID: 33051210
[TBL] [Abstract][Full Text] [Related]
6. Further study on the two pivotal parts of Hlg2 for the full hemolytic activity of staphylococcal gamma-hemolysin.
Yokota K; Sugawara N; Nariya H; Kaneko J; Tomita T; Kamio Y
Biosci Biotechnol Biochem; 1998 Sep; 62(9):1745-50. PubMed ID: 9805375
[TBL] [Abstract][Full Text] [Related]
7. Purification, cloning and characterization of variant LukE-LukD with strong leukocidal activity of staphylococcal bi-component leukotoxin family.
Morinaga N; Kaihou Y; Noda M
Microbiol Immunol; 2003; 47(1):81-90. PubMed ID: 12636257
[TBL] [Abstract][Full Text] [Related]
8. Identification of the essential amino acid residues in lukS for the hemolytic activity of staphylococcal leukocidin towards rabbit erythrocytes.
Nariya H; Shimatani A; Tomita T; Kamio Y
Biosci Biotechnol Biochem; 1997 Dec; 61(12):2095-9. PubMed ID: 9438990
[TBL] [Abstract][Full Text] [Related]
9. Cytotoxicity analysis of staphylococcal bi-component β-pore forming toxins using the CHO cells expressing human lymphocyte receptor CCR5.
Peng Z; Shibata N; Tada H; Kaneko J
Biosci Biotechnol Biochem; 2018 Dec; 82(12):2094-2097. PubMed ID: 30185128
[TBL] [Abstract][Full Text] [Related]
10. Analysis of the specificity of Panton-Valentine leucocidin and gamma-hemolysin F component binding.
Meyer F; Girardot R; Piémont Y; Prévost G; Colin DA
Infect Immun; 2009 Jan; 77(1):266-73. PubMed ID: 18838523
[TBL] [Abstract][Full Text] [Related]
11. The interaction of Staphylococcus aureus bi-component gamma-hemolysins and leucocidins with cells and lipid membranes.
Ferreras M; Höper F; Dalla Serra M; Colin DA; Prévost G; Menestrina G
Biochim Biophys Acta; 1998 Nov; 1414(1-2):108-26. PubMed ID: 9804914
[TBL] [Abstract][Full Text] [Related]
12. Intermolecular ionic interactions serve as a possible switch for stem release in the staphylococcal bi-component toxin for β-barrel pore assembly.
Takeda K; Tanaka Y; Abe N; Kaneko J
Toxicon; 2018 Dec; 155():43-48. PubMed ID: 30312693
[TBL] [Abstract][Full Text] [Related]
13. Controlling pore assembly of staphylococcal gamma-haemolysin by low temperature and by disulphide bond formation in double-cysteine LukF mutants.
Nguyen VT; Higuchi H; Kamio Y
Mol Microbiol; 2002 Sep; 45(6):1485-98. PubMed ID: 12354220
[TBL] [Abstract][Full Text] [Related]
14. Antibodies to S. aureus LukS-PV Attenuated Subunit Vaccine Neutralize a Broad Spectrum of Canonical and Non-Canonical Bicomponent Leukotoxin Pairs.
Adhikari RP; Kort T; Shulenin S; Kanipakala T; Ganjbaksh N; Roghmann MC; Holtsberg FW; Aman MJ
PLoS One; 2015; 10(9):e0137874. PubMed ID: 26367030
[TBL] [Abstract][Full Text] [Related]
15. Construction of a LukS-PV mutant of a staphylococcal Panton-Valentine leukocidin component having a high LukS-like function.
Shimatani A; Kaneko J; Tomita T; Kamio Y
Biosci Biotechnol Biochem; 1999 Oct; 63(10):1828-30. PubMed ID: 10586512
[TBL] [Abstract][Full Text] [Related]
16. Identification of the minimum segment in which the threonine246 residue is a potential phosphorylated site by protein kinase A for the LukS-specific function of staphylococcal leukocidin.
Nariya H; Nishiyama A; Kamio Y
FEBS Lett; 1997 Sep; 415(1):96-100. PubMed ID: 9326377
[TBL] [Abstract][Full Text] [Related]
17. Flow cytometric determination of Panton-Valentine leucocidin S component binding.
Gauduchon V; Werner S; Prévost G; Monteil H; Colin DA
Infect Immun; 2001 Apr; 69(4):2390-5. PubMed ID: 11254598
[TBL] [Abstract][Full Text] [Related]
18. Characterization of a leukocidin identified in Staphylococcus pseudintermedius.
Abouelkhair MA; Bemis DA; Giannone RJ; Frank LA; Kania SA
PLoS One; 2018; 13(9):e0204450. PubMed ID: 30261001
[TBL] [Abstract][Full Text] [Related]
19. Vitronectin and its fragments purified as serum inhibitors of Staphylococcus aureus gamma-hemolysin and leukocidin, and their specific binding to the hlg2 and the LukS components of the toxins.
Katsumi H; Tomita T; Kaneko J; Kamio Y
FEBS Lett; 1999 Nov; 460(3):451-6. PubMed ID: 10556515
[TBL] [Abstract][Full Text] [Related]
20. Composition of staphylococcal bi-component toxins determines pathophysiological reactions.
König B; Prévost G; König W
J Med Microbiol; 1997 Jun; 46(6):479-85. PubMed ID: 9350200
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
